Related Experiment Videos
[Thrombosis and tissue protection in microvascular surgery--an overview]
F W Peter1, R Büttemeyer, P M Vogt
1Klinik für Plastische Chirurgie, Handchirurgie und Schwerbrandverletzte, Universitätskliniken Bergmannsheil, Bochum.
Zentralblatt Fur Chirurgie
|January 1, 1997
Summary
Microvascular surgery complications like thrombosis can be reduced with antiplatelet and anticoagulant drugs. Aspirin and heparin are reliable clinical options to improve surgical outcomes and protect microcirculation.
Area of Science:
- Vascular Surgery
- Thrombosis Research
- Microcirculation Studies
Context:
- Microvascular surgery, despite advancements, faces failure primarily due to thrombosis.
- Thrombosis involves complex interactions of the vascular wall, platelets, and coagulation cascade.
- Tissue death can occur even with open anastomoses due to insufficient microcirculatory perfusion.
Purpose:
- To review the causes of microvascular surgery failure, focusing on thrombosis and ischemia-reperfusion injury.
- To discuss current pharmacological strategies for preventing and managing these complications.
- To highlight potential future therapeutic developments in antithrombotic agents.
Summary:
- The primary cause of microvascular surgery failure is thrombosis, affecting the vascular wall, platelets, and coagulation system.
- Insufficient microperfusion leading to vasoconstriction and ischemia-reperfusion injury (mediated by oxygen free radicals and leukocytes) also cause tissue damage.
- Pharmacological interventions including aspirin, heparin, and dextran are effective in reducing thrombosis and protecting microcirculation, with future developments focusing on targeted antithrombotic agents.
Impact:
- Provides a comprehensive overview of microvascular surgery failure mechanisms and current management strategies.
- Identifies key pharmacological agents (aspirin, heparin) for clinical use in preventing thrombosis and protecting microcirculation.
- Outlines future research directions for more specific and localized antithrombotic therapies to improve surgical success rates.